Adimmune Corp Capital Reinvestment Ratio
Adimmune Corp capital reinvestment ratio. Adimmune Corp (4142) has a Capital Reinvestment Ratio of 0.06x as of December 2024, meaning it reinvests 0% of its operating cash flow (NT$658.32 Million) in capital expenditures (NT$42.60 Million). Check 4142 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Adimmune Corp (2007–2024)
Capital reinvestment ratio of Adimmune Corp from 2007 to 2024. This chart tracks Adimmune Corp's Capital Reinvestment Ratio across 6 annual periods. Also explore 4142 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Adimmune Corp Capital Reinvestment Ratio by Year (2007–2024)
Adimmune Corp capital reinvestment ratio by year from 2007 to 2024. For the full cash flow conversion analysis, see 4142 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | NT$668.48 Million | NT$155.22 Million | ▲ +147.0% |
| 2020 | 0.09x | NT$2.32 Billion | NT$218.30 Million | ▼ -94.3% |
| 2017 | 1.65x | NT$6.87 Million | NT$11.35 Million | ▲ +36.1% |
| 2010 | 1.21x | NT$516.39 Million | NT$626.30 Million | ▲ +3.5% |
| 2009 | 1.17x | NT$600.42 Million | NT$703.82 Million | ▼ -86.2% |
| 2007 | 8.50x | NT$31.26 Million | NT$265.77 Million | — |